-
121
-
122
Hydrogen gas inhalation therapy may not work sufficiently to mitigate oxidative stress induced with REBOA
Published 2024-12-01Get full text
Article -
123
-
124
-
125
-
126
-
127
-
128
Occipital Condyle Fracture: A Case Report of a Typically Stable Fracture That Required Surgical Treatment
Published 2018-01-01Get full text
Article -
129
-
130
-
131
A multicenter study on TROP2 as a potential targeted therapy for extramammary Paget disease in Japan
Published 2025-01-01Get full text
Article -
132
Effectiveness of PK-Guided Personalized Recombinant FVIII Treatment in Patients with Hemophilia A: Clinical Case Experiences Based on an Observational Study
Published 2025-01-01“…Yoko Mizoguchi,1 Moeko Hino,2 Hitoshi Ueda,3 Yasuo Miyaguchi,3 Masao Kobayashi1,4 1Department of Pediatrics, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan; 2Department of Pediatrics, Chiba University Hospital, Chiba, Japan; 3Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan; 4Japanese Red Cross, Chugoku-Shikoku Block Blood Center, Hiroshima, JapanCorrespondence: Yasuo Miyaguchi, Japan Medical Office, Takeda Pharmaceutical Company Limited, 2 Chome-1-1 Nihonbashihoncho, Chuo-ku, Tokyo, 103-0023, Japan, Tel +81 70-4921-7966, Email yasuo.miyaguchi1@takeda.comPurpose: Prophylaxis with recombinant factor VIII (rFVIII) products is the gold-standard treatment for hemophilia A. …”
Get full text
Article -
133
Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan
Published 2024-03-01Get full text
Article -
134
-
135
Office environment and employee differences by company health management certification
Published 2024-12-01Get full text
Article -
136
-
137
-
138
-
139
A CNN-RF Hybrid Approach for Rice Paddy Fields Mapping in Indramayu Using Sentinel-1 and Sentinel-2 Data
Published 2025-01-01Get full text
Article -
140